切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - c-MET - D4 Receptors

11件产品中的 1-10

页面
每页
清除全部
  1. Altiratinib
    B5832 Altiratinib
     1 Citation
    Target: FLT3|VEGFR|Trk Receptors|c-MET|Tie-2
    Summary: c-MET/TIE-2/VEGFR抑制剂
      ≥21.55 mg/mL
      insoluble in H2O
  2. Pramipexole
    B1488 Pramipexole
    中文名: 普拉克索
    Target: D2 Receptors|D3 Receptors|D4 Receptors
    Summary: 多巴胺激动剂
      ≥10.57 mg/mL
      insoluble in H2O
  3. Clozapine
    B2235 Clozapine
    中文名: 氯氮平
    Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|D4 Receptors
    Summary: 5-HT受体拮抗剂
      ≥14.95 mg/mL
      insoluble in H2O
  4. Thioridazine HCl
    A8537 Thioridazine HCl
    中文名: 盐酸硫利达嗪,盐酸硫代利哒,甲硫达嗪盐酸盐,甲硫哒嗪盐酸盐
    Target: Cytochrome P450 (CYP450)|D1 and D5 Receptors|D2 Receptors|D3 Receptors|D4 Receptors
    Summary: 钙通道蛋白抑制剂
      ≥20.35 mg/mL
      ≥6.78 mg/mL
  5. INCB28060
    A8448 INCB28060
    中文名: 苯扎米特
    Target: c-MET
    Summary: C-Met抑制剂
      ≥5.15 mg/mL
      insoluble in H2O
  6. MGCD-265
    A5057 MGCD-265
    Target: VEGFR|c-MET
    Summary: Met/Flt/Flk/Ron/Tie-2抑制剂
      ≥25.9 mg/mL
      insoluble in H2O
  7. CP-724714
    A2412 CP-724714
    Target: VEGFR|PDGFR|Bcr-Abl|Src|EGFR|c-MET|Insulin Receptors|IRG-1R
    Summary: 有效的HER2选择性抑制剂
      ≥23.5 mg/mL
      insoluble in H2O
  8. PF-04217903
    A5096 PF-04217903
    Target: c-MET
    Summary: C-Met的选择性和ATP竞争性抑制剂
      ≥18.6 mg/mL
      insoluble in H2O
  9. PHA-665752
    A2307 PHA-665752
     1 Citation
    Target: c-MET
    Summary: c-Met的ATP竞争性、有效的、选择性抑制剂
      ≥32.1 mg/mL
      insoluble in H2O
  10. PF-04217903 methanesulfonate
    A3712 PF-04217903 methanesulfonate
    Target: c-MET
    Summary: c-Met抑制剂
      Soluble in DMSO

11件产品中的 1-10

页面
每页